Janssen Announces Preliminary Results from Phase 2 GALAHAD Study in Adults with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Pathway Defects (DRD)
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Gastroschisis Repair | Pharmaceuticals | Prostate Cancer | Study